0001415889-24-000277.txt : 20240103
0001415889-24-000277.hdr.sgml : 20240103
20240103161525
ACCESSION NUMBER: 0001415889-24-000277
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240101
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brennan Kevin M.
CENTRAL INDEX KEY: 0001971303
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 24506558
MAIL ADDRESS:
STREET 1: C/O XILIO THERAPEUTICS, INC.
STREET 2: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-01032024_040103.xml
X0508
4
2024-01-01
0001840233
Xilio Therapeutics, Inc.
XLO
0001971303
Brennan Kevin M.
828 WINTER STREET
SUITE 300
WALTHAM
MA
02451
false
true
false
false
SVP, FINANCE AND ACCOUNTING
0
Restricted Stock Units
2024-01-01
4
A
0
20000
0
A
Common Stock
20000
20000
D
Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
These RSUs were granted on January 1, 2024 and will vest in four equal annual installments beginning on January 1, 2025 and continuing through January 1, 2028.
/s/ Julia Walcott, Attorney-in-Fact
2024-01-03